rxstat › Shortages › Candesartan Cilexetil

Candesartan Cilexetil shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Candesartan Cilexetil products are in shortage in Canada (20 of 59 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2020.
Products affected
20 of 59
In shortage since
Sep 15, 2016
Est. full return
Dec 31, 2020
Reports on file
269
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-CANDESARTAN TABLETS
8MG · TABLET · APOTEX INC
DIN 02541297 · since Apr 28, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
16MG · TABLET · APOTEX INC
DIN 02541300 · since Apr 21, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
8MG · TABLET · APOTEX INC
DIN 02541297 · since Mar 24, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
4MG · TABLET · APOTEX INC
DIN 02541289 · since Aug 19, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
4MG · TABLET · APOTEX INC
DIN 02541289 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
32MG · TABLET · APOTEX INC
DIN 02541319 · since Feb 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CANDESARTAN TABLETS
16MG · TABLET · APOTEX INC
DIN 02541300 · since Feb 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-CANDESARTAN
8MG · TABLET · ACCORD HEALTHCARE INC
DIN 02379279 · since Dec 6, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
CANDESARTAN
8MG · TABLET · SANIS HEALTH INC
DIN 02388928 · since Aug 23, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CANDESARTAN
32MG · TABLET · SANIS HEALTH INC
DIN 02435845 · since Aug 30, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CANDESARTAN
16MG · TABLET · SANIS HEALTH INC
DIN 02388936 · since Sep 9, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CANDESARTAN
4MG · TABLET · SANIS HEALTH INC
DIN 02388901 · since Apr 9, 2024, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Candesartan Cilexetil is currently affected by 20 active shortage reports filed with Health Canada by APOTEX INC, ACCORD HEALTHCARE INC, SANIS HEALTH INC, JAMP PHARMA CORPORATION and 1 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; demand increase for the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Candesartan Cilexetil is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).

Recent changes

Common questions

When will Candesartan Cilexetil be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2020. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Candesartan Cilexetil in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, plain)

Partial shortageIrbesartan10 of 43 reported products affected · est. return Dec 30, 2022Partial shortageLosartan16 of 45 reported products affected · est. return Dec 31, 2026Partial shortageOlmesartan Medoxomil2 of 24 reported products affectedPartial shortageTelmisartan3 of 26 reported products affectedPartial shortageValsartan3 of 43 reported products affected · est. return Jun 19, 2026No current shortageAzilsartan Medoxomil

All angiotensin ii antagonists, plain shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.